ESSA Pharma adjourns special meeting to Sep 29 for continued talks on Xeno deal terms

ESSA Pharma Inc.

Special meeting postponed from Sep 10 to 2:00 p.m. PT on Sep 29, 2025.
Adjournment allows time to discuss revised financial terms, including upfront cash to shareholders.
British Columbia Supreme Court approval hearing moved from Sep 12; new date to be announced.
All previously voted shareholders do not need to take any action.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.